Centre of Excellence for Long-acting Therapeutics
banner
celtliverpool.bsky.social
Centre of Excellence for Long-acting Therapeutics
@celtliverpool.bsky.social
The Centre of Excellence for Long-acting Therapeutics (CELT) at #livuni is accelerating understanding of #longacting medicines, by combining world leading expertise in pharmacology and materials chemistry to create new interventions.
This week's long-acting news from other teams includes:

🫁 Generate:Biomedicines - phase 3 trials of a 6 month asthma treatment
💉@who.int call for rapid expansion of access to new WHO-approved tools to drive down infections on World AIDS Day

Read the full stories
www.liverpool.ac.uk/centre-of-ex...
December 5, 2025 at 2:17 PM
📣 SPEAKER ANNOUNCEMENT
We're excited to announce the speakers for the first of our new workshop series; LA-LINK
Professor Robert Bies - @ubuffalo.bsky.social
Dr. Harshal Hattyangdi - @liverpooluni.bsky.social
Dr. Catia Marzolini - @unil.bsky.social & @unibas.ch
Dr. @fwojara - Gulu University, Uganda
December 4, 2025 at 12:42 PM
Our next Community of Practice for long-acting therapeutics for maternal and paediatric health webinar

⭐Designing for the long haul: Lessons for safety studies of long-acting therapeutics from pregnancy through childhood
📆4 February 2026
🗣️Dr Adeniyi Olagunju

www.liverpool.ac.uk/centre-of-ex...
November 26, 2025 at 12:14 PM
Are you signed up to the quarterly #LONGEVITYproject newsletter?

The international consortium aim to bring long-acting preventatives/treatments to HCV, malaria and TB patients in LMICs, where these diseases have the biggest impact.

Sign up: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
November 25, 2025 at 1:02 PM
20 November is United Nations' #WorldChildrensDay.

How do we advocate for children and keep them safe?

We are actively working on child safety; to prevent malaria, and to create better pathways for children within long-acting clinical research.

Read how:
www.liverpool.ac.uk/centre-of-ex...
November 20, 2025 at 12:58 PM
17-23 November is @worldhepalliance.bsky.social #WorldHepatitisTestingWeek.
We wrote a blog on hepatitis testing as a global issue
The #LONGEVITYproject, is working on a one-shot-cure for HCV to provide patients in LMICs treatment at diagnosis
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
November 19, 2025 at 12:19 PM
📣 We're launching LA-LINK!

A new quarterly online workshop series from researchers, regulators, manufacturers, patient advocates, funders and more.

⭐Application of pharmacokinetic modelling and simulation for long-acting medicines
📆29 January
✅Registration soon

www.liverpool.ac.uk/centre-of-ex...
November 18, 2025 at 12:39 PM
🌟Securing the Future: Shaping the UK Strategy on Long-acting Therapeutics🌟

We were proud to host a collaborative event at the Liver Building, bringing together leaders from industry, academia, NHS, and regulatory bodies to shape the UK’s future long-acting therapeutics strategy.
November 17, 2025 at 1:23 PM
This #WorldDiabetesDay, our global long-acting therapeutics news:

💉 ADOCIA: once a month diabetes injection
🔬 SanegeneBio and Innovent: six-monthly hypertension injection
🫀 Rona Therapeutics: reduce ApoC3 and triglycerides

Read more:
www.liverpool.ac.uk/centre-of-ex...
November 14, 2025 at 12:39 PM
A video of our October Community of Practice session is live.

Laxman Cherkupally from @mmv.org delivered the session titled 'Considerations for long-acting injectable microsuspension development - Lessons from an anti-malarial therapy'

Watch here: youtu.be/3PTuh4sfA4g
November 13, 2025 at 12:17 PM
Calling Clinical Pharmacologists!
Are you keen to make data from published studies count beyond the paper?

PKRxiv is a managed open-access repository and visualization platform for collaborative sharing of anonymised, PK data and associated covariates.
www.liverpool.ac.uk/centre-of-ex...
November 11, 2025 at 12:27 PM
Managed by @medicinespatentpool.org, LAPaL is a public database providing data on long-acting therapeutics and drug delivery technologies
This month's updates:
Long-acting semaglutide - updated global reg status and clinical trials
Lenacapavir - updated reg status
www.liverpool.ac.uk/centre-of-ex...
October 30, 2025 at 3:03 PM
29 October is @unesco.org's #WorldCodingDay.

It might not be clear how programming helps our goals to save patient lives through long-acting therapeutics, but it's actually a key part of our work.

Find out how in our blog piece:
www.liverpool.ac.uk/centre-of-ex...
October 29, 2025 at 12:31 PM
'Securing the future: Shaping the UK strategy on long-acting therapeutics' is the first event of the UK Hub for Advanced Long-acting Therapeutics (HALo).

📆 Thursday 6 November 2025
⏰ 10am-4pm
🌍 Liverpool, UK

Find the agenda and how to register: www.liverpool.ac.uk/centre-of-ex...
@ukri.org
October 28, 2025 at 2:13 PM
Exciting recent long-acting news from other teams includes:

@nhsengland.bsky.social roll out cabotegravir, two monthly HIV PrEP
ViiV show cabotegravir is more acceptable than lenacapavir
FDA approved @tevapharm.bsky.social UZEDY for bipolar I disorder

www.liverpool.ac.uk/centre-of-ex...
October 24, 2025 at 2:31 PM
Are you subscribed to our quarterly #LONGEVITYproject newsletter?

We update LONGEVITY news, opportunities and global events.
LONGEVITY, funded by @unitaid.bsky.social, is working to create long-acting malaria, TB and HCV medicines for patients in LMICs.

Sign up: www.liverpool.ac.uk/centre-of-ex...
October 23, 2025 at 11:53 AM
Have you used Teoreler for any research that has since been published?

If so, we'd like to add you to the list of publications Teoreler was used for: www.liverpool.ac.uk/centre-of-ex...

Email us on [email protected]
October 22, 2025 at 11:50 AM
Dr Cameron Hogarth leads our Manufacturing Capability project, aiming to create an open-access resource of manufacturers' long-acting capabilities in LMICs.

Connecting to organisations is a powerful way to find necessary data.

Read more: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
October 14, 2025 at 11:53 AM
This #ChildHealthDay we're highlighting our upcoming Community of Practice webinar, hosted by Laxman Cherkupally from @mmv.org on 22 October.

The majority of malaria deaths are children under 5 years old. All malaria work is to protect children health.
events.teams.microsoft.com/event/8ad398...
October 7, 2025 at 11:33 AM
#ManufacturingDay is the last Thursday of September (UK - @makeuk.bsky.social) and the first Friday of October (US)

We're leading the Manufacturing Capability project to create an open resource to show manufacturing capabilities in LMICs:
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
October 3, 2025 at 11:17 AM
9 October, CELT's Prajith Venkatasubramanian is delivering a webinar with Dr Leena Zino.

They'll discuss long acting drug delivery systems and the patents / regulatory process.

Find out more about this and other events CELT are at via our event page:
www.liverpool.ac.uk/centre-of-ex...
October 2, 2025 at 2:35 PM
The Systems Medicine team have published: Physiologically based pharmacokinetic modelling of serum 25-hydroxyvitamin D concentrations in schoolchildren receiving weekly oral vitamin D3 supplementation

Find a link to the full article and other CELT publications: www.liverpool.ac.uk/centre-of-ex...
October 1, 2025 at 11:35 AM
Teoreler is a free online PBPK modelling application. With support from @unitaid.bsky.social, our team work really hard to continually update Teoreler and add new models.

Find out more if you're new to Teoreler, or leave us feedback if you're not, via the link: www.liverpool.ac.uk/centre-of-ex...
September 30, 2025 at 11:02 AM
28 September was @unesco.org's International Day for Universal Access to Information.

We've told you why we think patients accessing research that represents them is important. Now we can show you how we're doing it.

www.liverpool.ac.uk/centre-of-ex...
#AccessToInfo #AccessToInfoDay #RightToKnow
September 29, 2025 at 2:08 PM
News from other long-acting teams:

- @unitaid.bsky.social, Clinton Health Access Initiative and Wits RHI: agreement with Dr Reddy's Laboratories to make affordable lenacapavir
- @unaids.org respond to the announcement of making affordable HIV preventatives.

www.liverpool.ac.uk/centre-of-ex...
September 26, 2025 at 11:26 AM